Report Detail

Request for Sample of this report

Other Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market 2020 by Company, Type and Application, Forecast to 2025

  • RnM3904120
    • |
  • 23 March, 2020
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Market Overview
The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 million in 2019.

The Point-of-Care Infectious Disease Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Point-of-Care Infectious Disease Diagnostics/Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented into:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC

By Application, Point-of-Care Infectious Disease Diagnostics/Testing has been segmented into:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Point-of-Care Infectious Disease Diagnostics/Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Point-of-Care Infectious Disease Diagnostics/Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point-of-Care Infectious Disease Diagnostics/Testing market.

The report offers in-depth assessment of the growth and other aspects of the Point-of-Care Infectious Disease Diagnostics/Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Point-of-Care Infectious Disease Diagnostics/Testing Market Share Analysis
Point-of-Care Infectious Disease Diagnostics/Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Point-of-Care Infectious Disease Diagnostics/Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point-of-Care Infectious Disease Diagnostics/Testing sales, revenue and market share for each player covered in this report.

The major players covered in Point-of-Care Infectious Disease Diagnostics/Testing are:
Abbott
Cardinal Health
Siemens Healthineers
Thermo Fisher Scientific Inc
Trinity Biotech
F. Hoffmann-La Roche Ltd
Bio-Rad Labs Inc.
Chembio Diagnostics Inc.
BD & Company
Quest Diagnostics Inc.
OJ-Bio Ltd.
bioMérieux SA
Ortho-Clinical Diagnostics
Trivitron Healthcare
Sight Diagnostics Ltd.
Gene POC


Table of Contents

    1 Point-of-Care Infectious Disease Diagnostics/Testing Market Overview

    • 1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics/Testing
    • 1.2 Classification of Point-of-Care Infectious Disease Diagnostics/Testing by Type
      • 1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
      • 1.2.3 HIV POC
      • 1.2.4 Clostridium difficile POC
      • 1.2.5 HBV POC
      • 1.2.6 Pneumonia or Streptococcus associated infections
      • 1.2.7 Respiratory syncytial virus (RSV) POC
      • 1.2.8 HPV POC
      • 1.2.9 Influenza/Flu POC
      • 1.2.10 Other Infectious Disease POC
    • 1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Application
      • 1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Home
      • 1.3.5 Assisted Living Healthcare Facilities
      • 1.3.6 Laboratories
      • 1.3.7 Others
    • 1.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Regions
      • 1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Point-of-Care Infectious Disease Diagnostics/Testing (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Abbott
      • 2.1.1 Abbott Details
      • 2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Abbott SWOT Analysis
      • 2.1.4 Abbott Product and Services
      • 2.1.5 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Cardinal Health
      • 2.2.1 Cardinal Health Details
      • 2.2.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Cardinal Health SWOT Analysis
      • 2.2.4 Cardinal Health Product and Services
      • 2.2.5 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Siemens Healthineers
      • 2.3.1 Siemens Healthineers Details
      • 2.3.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Siemens Healthineers SWOT Analysis
      • 2.3.4 Siemens Healthineers Product and Services
      • 2.3.5 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Thermo Fisher Scientific Inc
      • 2.4.1 Thermo Fisher Scientific Inc Details
      • 2.4.2 Thermo Fisher Scientific Inc Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Thermo Fisher Scientific Inc SWOT Analysis
      • 2.4.4 Thermo Fisher Scientific Inc Product and Services
      • 2.4.5 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Trinity Biotech
      • 2.5.1 Trinity Biotech Details
      • 2.5.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Trinity Biotech SWOT Analysis
      • 2.5.4 Trinity Biotech Product and Services
      • 2.5.5 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 F. Hoffmann-La Roche Ltd
      • 2.6.1 F. Hoffmann-La Roche Ltd Details
      • 2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
      • 2.6.4 F. Hoffmann-La Roche Ltd Product and Services
      • 2.6.5 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Bio-Rad Labs Inc.
      • 2.7.1 Bio-Rad Labs Inc. Details
      • 2.7.2 Bio-Rad Labs Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Bio-Rad Labs Inc. SWOT Analysis
      • 2.7.4 Bio-Rad Labs Inc. Product and Services
      • 2.7.5 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Chembio Diagnostics Inc.
      • 2.8.1 Chembio Diagnostics Inc. Details
      • 2.8.2 Chembio Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Chembio Diagnostics Inc. SWOT Analysis
      • 2.8.4 Chembio Diagnostics Inc. Product and Services
      • 2.8.5 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 BD & Company
      • 2.9.1 BD & Company Details
      • 2.9.2 BD & Company Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 BD & Company SWOT Analysis
      • 2.9.4 BD & Company Product and Services
      • 2.9.5 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Quest Diagnostics Inc.
      • 2.10.1 Quest Diagnostics Inc. Details
      • 2.10.2 Quest Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Quest Diagnostics Inc. SWOT Analysis
      • 2.10.4 Quest Diagnostics Inc. Product and Services
      • 2.10.5 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 OJ-Bio Ltd.
      • 2.11.1 OJ-Bio Ltd. Details
      • 2.11.2 OJ-Bio Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 OJ-Bio Ltd. SWOT Analysis
      • 2.11.4 OJ-Bio Ltd. Product and Services
      • 2.11.5 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 bioMérieux SA
      • 2.12.1 bioMérieux SA Details
      • 2.12.2 bioMérieux SA Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 bioMérieux SA SWOT Analysis
      • 2.12.4 bioMérieux SA Product and Services
      • 2.12.5 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Ortho-Clinical Diagnostics
      • 2.13.1 Ortho-Clinical Diagnostics Details
      • 2.13.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Ortho-Clinical Diagnostics SWOT Analysis
      • 2.13.4 Ortho-Clinical Diagnostics Product and Services
      • 2.13.5 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Trivitron Healthcare
      • 2.14.1 Trivitron Healthcare Details
      • 2.14.2 Trivitron Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Trivitron Healthcare SWOT Analysis
      • 2.14.4 Trivitron Healthcare Product and Services
      • 2.14.5 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Sight Diagnostics Ltd.
      • 2.15.1 Sight Diagnostics Ltd. Details
      • 2.15.2 Sight Diagnostics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Sight Diagnostics Ltd. SWOT Analysis
      • 2.15.4 Sight Diagnostics Ltd. Product and Services
      • 2.15.5 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 Gene POC
      • 2.16.1 Gene POC Details
      • 2.16.2 Gene POC Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 Gene POC SWOT Analysis
      • 2.16.4 Gene POC Product and Services
      • 2.16.5 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
      • 3.2.2 Top 10 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions
    • 4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 4.5 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    5 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

    • 5.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
    • 5.2 USA Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    6 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

    • 6.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
    • 6.2 Germany Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 6.3 UK Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 6.4 France Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

    • 7.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
    • 7.2 China Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 7.5 India Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    8 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries

    • 8.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
    • 8.2 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Point-of-Care Infectious Disease Diagnostics/Testing by Countries

    • 9.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Type (2019-2024)
    • 10.3 HIV POC Revenue Growth Rate (2015-2025)
    • 10.4 Clostridium difficile POC Revenue Growth Rate (2015-2025)
    • 10.5 HBV POC Revenue Growth Rate (2015-2025)
    • 10.6 Pneumonia or Streptococcus associated infections Revenue Growth Rate (2015-2025)
    • 10.7 Respiratory syncytial virus (RSV) POC Revenue Growth Rate (2015-2025)
    • 10.8 HPV POC Revenue Growth Rate (2015-2025)
    • 10.9 Influenza/Flu POC Revenue Growth Rate (2015-2025)
    • 10.10 Other Infectious Disease POC Revenue Growth Rate (2015-2025)

    11 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Segment by Application

    • 11.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application (2015-2020)
    • 11.2 Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2015-2020)
    • 11.4 Clinics Revenue Growth (2015-2020)
    • 11.5 Home Revenue Growth (2015-2020)
    • 11.6 Assisted Living Healthcare Facilities Revenue Growth (2015-2020)
    • 11.7 Laboratories Revenue Growth (2015-2020)
    • 11.8 Others Revenue Growth (2015-2020)

    12 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)

    • 12.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)
    • 12.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Regions (2021-2025)
    • 12.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
    • 12.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
    • 12.6 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Point-of-Care Infectious Disease Diagnostics/Testing. Industry analysis & Market Report on Point-of-Care Infectious Disease Diagnostics/Testing is a syndicated market report, published as Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market 2020 by Company, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Point-of-Care Infectious Disease Diagnostics/Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,770.08
      		4,155.12
      		5,540.16
      		3,232.92
      		4,849.38
      		6,465.84
      		535,711.20
      		803,566.80
      		1,071,422.40
      		290,614.80
      		435,922.20
      		581,229.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo